Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Harrison Graham Pope Jr., M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01DA029141 (POPE, HARRISON G) Feb 1, 2011 - Nov 30, 2015
    Medical Consequences of Long-Term Anabolic-Androgenic Steroid Abuse
    Role: Principal Investigator
  2. R01DA016744 (POPE, HARRISON G) Mar 1, 2005 - Feb 28, 2010
    Risk Factors for Anabolic-Androgenic Steroid Abuse
    Role: Principal Investigator
  3. R37DA010346 (POPE, HARRISON G) Sep 1, 1996 - Jul 31, 2004
    Role: Principal Investigator
  4. R01DA010346 (POPE, HARRISON G) Sep 1, 1996 - Jul 31, 2000
    Role: Principal Investigator
  5. R01DA010055 (POPE, HARRISON G) Mar 1, 1996 - Feb 28, 1998
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Hudson JI, Kanayama G, Pope HG, Muse S, Kaufman MJ, Baggish A, Waikar SS. Glomerular Filtration Rate and Supraphysiologic-Dose Anabolic-Androgenic Steroid Use: A Cross-sectional Cohort Study. Am J Kidney Dis. 2020 07; 76(1):152-155. PMID: 32362416.
    Citations: 1     Fields:    Translation:Humans
  2. Kanayama G, Hudson JI, Pope HG. Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians. Psychother Psychosom. 2020; 89(2):65-73. PMID: 32066136.
    Citations: 1     Fields:    Translation:Humans
  3. Steele IH, Pope HG, Kanayama G. Competitive Bodybuilding: Fitness, Pathology, or Both? Harv Rev Psychiatry. 2019 Jul/Aug; 27(4):233-240. PMID: 31219882.
    Citations: 1     Fields:    Translation:Humans
  4. Goldman AL, Goldman AL, Pope HG, Bhasin S. The Health Threat Posed by the Hidden Epidemic of Anabolic Steroid Use and Body Image Disorders Among Young Men. J Clin Endocrinol Metab. 2019 04 01; 104(4):1069-1074. PMID: 30239802.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  5. Kaufman MJ, Kanayama G, Hudson JI, Pope HG. Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Neurosci Biobehav Rev. 2019 05; 100:180-207. PMID: 30817935.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  6. Ip EJ, Doroudgar S, Shah-Manek B, Barnett MJ, Tenerowicz MJ, Ortanez M, Pope HG. The CASTRO study: Unsafe sexual behaviors and illicit drug use among gay and bisexual men who use anabolic steroids. Am J Addict. 2019 02; 28(2):101-110. PMID: 30724428.
    Citations:    Fields:    Translation:Humans
  7. Hudson JI, Pope HG. Evolving Perspectives on the Public Health Burden of Eating Disorders. Biol Psychiatry. 2018 09 01; 84(5):318-319. PMID: 30115240.
    Citations:    Fields:    Translation:HumansPHPublic Health
  8. Brennan BP, Wang D, Li M, Perriello C, Ren J, Elias JA, Van Kirk NP, Krompinger JW, Pope HG, Haber SN, Rauch SL, Baker JT, Liu H. Use of an Individual-Level Approach to Identify Cortical Connectivity Biomarkers in Obsessive-Compulsive Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 01; 4(1):27-38. PMID: 30262337.
    Citations: 9     Fields:    Translation:Humans
  9. Kanayama G, Kaufman MJ, Pope HG. Public health impact of androgens. Curr Opin Endocrinol Diabetes Obes. 2018 06; 25(3):218-223. PMID: 29369918.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  10. Barnett BS, Siu WO, Pope HG. A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens. J Nerv Ment Dis. 2018 06; 206(6):476-480. PMID: 29781894.
    Citations:    Fields:    Translation:Humans
  11. Ulrich R, Pope HG, Cléret L, Petróczi A, Nepusz T, Schaffer J, Kanayama G, Comstock RD, Simon P. Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys. Sports Med. 2018 01; 48(1):211-219. PMID: 28849386.
    Citations: 16     Fields:    Translation:Humans
  12. Brennan BP, Admon R, Perriello C, LaFlamme EM, Athey AJ, Pizzagalli DA, Hudson JI, Pope HG, Jensen JE. Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram. Psychiatry Res Neuroimaging. 2017 Nov 30; 269:9-16. PMID: 28892734.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  13. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017 May 23; 135(21):1991-2002. PMID: 28533317.
    Citations: 31     Fields:    Translation:Humans
  14. Ip EJ, Yadao MA, Shah BM, Doroudgar S, Perry PJ, Tenerowicz MJ, Newsom L, Mann AA, Mkrtchyan H, Pope HG. Polypharmacy, Infectious Diseases, Sexual Behavior, and Psychophysical Health Among Anabolic Steroid-Using Homosexual and Heterosexual Gym Patrons in San Francisco's Castro District. Subst Use Misuse. 2017 06 07; 52(7):959-968. PMID: 28296533.
    Citations:    Fields:    Translation:Humans
  15. Kanayama G, Pope HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018 03 15; 464:4-13. PMID: 28245998.
    Citations: 10     Fields:    Translation:Humans
  16. Pope HG, Khalsa JH, Bhasin S. Body Image Disorders and Abuse of Anabolic-Androgenic Steroids Among Men. JAMA. 2017 01 03; 317(1):23-24. PMID: 27930760.
    Citations: 8     Fields:    Translation:Humans
  17. Seitz J, Lyall AE, Kanayama G, Makris N, Hudson JI, Kubicki M, Pope HG, Kaufman MJ. White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study. Psychiatry Res Neuroimaging. 2017 Feb 28; 260:1-5. PMID: 27988413.
    Citations: 5     Fields:    Translation:Humans
  18. Brennan BP, Jensen JE, Perriello C, Pope HG, Jenike MA, Hudson JI, Rauch SL, Kaufman MJ. LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Feb 01; 1(2):116-124. PMID: 26949749.
    Citations: 7     Fields:    
  19. Kanayama G, DeLuca J, Meehan WP, Hudson JI, Isaacs S, Baggish A, Weiner R, Micheli L, Pope HG. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study. Am J Sports Med. 2015 Nov; 43(11):2638-44. PMID: 26362436.
    Citations: 18     Fields:    Translation:Humans
  20. Hallgren M, Pope HG, Kanayama G, Hudson JI, Lundin A, Källmén H. Anti-Social Behaviors Associated with Anabolic-Androgenic Steroid Use among Male Adolescents. Eur Addict Res. 2015; 21(6):321-6. PMID: 26113433.
    Citations: 3     Fields:    Translation:Humans
  21. Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, Jensen JE, Pope HG. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2015 Jul 01; 152:47-56. PMID: 25986964.
    Citations: 18     Fields:    Translation:Humans
  22. Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction. 2015 May; 110(5):823-31. PMID: 25598171.
    Citations: 14     Fields:    Translation:Humans
    Citations: 6     
  24. Mangweth-Matzek B, Hoek HW, Pope HG. Pathological eating and body dissatisfaction in middle-aged and older women. Curr Opin Psychiatry. 2014 Nov; 27(6):431-5. PMID: 25247455.
    Citations: 8     Fields:    Translation:Humans
  25. Brennan BP, Lee C, Elias JA, Crosby JM, Mathes BM, Andre MC, Gironda CM, Pope HG, Jenike MA, Fitzmaurice GM, Hudson JI. Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response. J Psychiatr Res. 2014 Sep; 56:98-105. PMID: 24909787.
    Citations: 4     Fields:    Translation:Humans
  26. Pope HG, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014 Jun; 35(3):341-75. PMID: 24423981.
    Citations: 79     Fields:    Translation:Humans
  27. Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG, Renshaw PF, Cohen BM. A placebo-controlled trial of acetyl-L-carnitine and a-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol. 2013 Oct; 33(5):627-35. PMID: 23948785.
    Citations: 11     Fields:    Translation:HumansCells
  28. Pope HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014 Jul-Aug; 23(4):371-7. PMID: 24112239.
    Citations: 37     Fields:    Translation:Humans
  29. Mangweth-Matzek B, Hoek HW, Rupp CI, Kemmler G, Pope HG, Kinzl J. The menopausal transition--a possible window of vulnerability for eating pathology. Int J Eat Disord. 2013 Sep; 46(6):609-16. PMID: 23847142.
    Citations: 10     Fields:    Translation:Humans
  30. Brennan BP, Kanayama G, Pope HG. Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict. 2013 Mar-Apr; 22(2):158-61. PMID: 23414502.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  31. Kanayama G, Kean J, Hudson JI, Pope HG. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):208-14. PMID: 23253252.
    Citations: 22     Fields:    Translation:Humans
  32. Kersey RD, Elliot DL, Goldberg L, Kanayama G, Leone JE, Pavlovich M, Pope HG. National Athletic Trainers' Association position statement: anabolic-androgenic steroids. J Athl Train. 2012 Sep-Oct; 47(5):567-88. PMID: 23068595.
    Citations: 12     Fields:    Translation:Humans
  33. Brennan BP, Rauch SL, Jensen JE, Pope HG. A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder. Biol Psychiatry. 2013 Jan 01; 73(1):24-31. PMID: 22831979.
    Citations: 38     Fields:    Translation:Humans
  34. Silverman BC, Asby A, Brendel DH, Choras P, Chu JA, Holman J, Pope HG, Radden J, Samson JA, Smith GW, Tsimprea G, Bodkin JA. Psychiatric treatment of the VIP: some paradoxical risks. J Nerv Ment Dis. 2012 Jun; 200(6):545-8. PMID: 22652622.
    Citations: 1     Fields:    Translation:Humans
  35. Kanayama G, Pope HG. Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes. 2012 Jun; 19(3):211-9. PMID: 22450858.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  36. Kanayama G, Hudson JI, Pope HG. Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom. 2012; 81(2):73-8. PMID: 22261875.
    Citations: 3     Fields:    Translation:Humans
  37. Pope HG, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012 Feb 01; 71(3):254-61. PMID: 21839424.
    Citations: 25     Fields:    Translation:Humans
  38. Kanayama G, Pope HG. Gods, men, and muscle dysmorphia. Harv Rev Psychiatry. 2011 Mar-Apr; 19(2):95-8. PMID: 21425938.
    Citations: 2     Fields:    Translation:Humans
  39. Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction. 2011 Apr; 106(4):777-86. PMID: 21205042.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  40. Amiaz R, Pope HG, Mahne T, Kelly JF, Brennan BP, Kanayama G, Weiser M, Hudson JI, Seidman SN. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011; 37(4):243-54. PMID: 21707327.
    Citations: 9     Fields:    Translation:Humans
  41. <